[Immunoregulation in the treatment of patients with acute pancreatitis].
The article analyses certain indicators of immune reactivity in 67 patients with different forms of pancreatitis. Lower reactivity of the organism in destructive pancreatitis determines the necessary use of immune modulating therapy in the complex treatment of this disease and purulent complications. In patients with high risk of pyo-septic complications the administration of cytostatics is not indicated.
D000208:Acute Disease; D000276:Adjuvants, Immunologic; D000328:Adult; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007978:Levamisole
Immunoreguliatsiia pri lechenii bol'nykh ostrym pankreatitom.